Stock Price

A company trading in fractions of a penny executes an extreme reverse stock split. Is this a desperate act of financial engineering or a strategic pivot?

The deal creates a $2.6 billion community bank, First Bank Midwest, aiming to blend tradition with scale. What does this mean for customers and the market?

A junior miner rebrands and moves to Montréal, betting its future on Québec's ambitious critical minerals strategy and a portfolio beyond just lithium.

With record backlogs and surging demand in defense and clean energy, all eyes are on BWX Technologies' Q2 results to see if its momentum can justify a soaring valuation.

By wiping its convertible debt and raising $170M, NextNav isn't just cleaning its books—it's signaling a full-scale assault on the PNT market.

A class action lawsuit alleges Graphic Packaging misled shareholders on inventory and demand, leading to major losses. A deep dive into the claims and what they mean.

Summit Hotel Properties' new credit facility isn't just a balance sheet move. It's a war chest for expansion, signaling strong lender confidence and growth.

With its iOS app approved, Hop-on Inc.'s Digitalage platform is live. Can its aggressive 85/15 revenue split and patent-pending tech reshape a $250B market?

The tech firm's new funding addresses urgent debt amid Nasdaq delisting threats, revealing a complex financial maneuver to keep its K-culture dreams alive.

Facing a mountain of debt, Sable Offshore Corp. is raising capital to refinance and restart controversial oil operations, sending its stock plunging.

Flash Sports & Media aims to vertically integrate with a creative, no-cash deal. But does the ambitious strategy align with its precarious financial reality?

As QXO finalizes its TopBuild acquisition, an overwhelming shareholder preference for cash triggers proration, reshaping investor portfolios and an entire industry.

Sheldon Inwentash's exit from One Bullion's board post-IPO is a classic junior miner move. What does it signal for the company's Botswana gold strategy?

Plus Therapeutics rebrands to Cerenome, signaling a major pivot to an integrated platform combining diagnostics, radiotherapeutics, and AI for CNS cancers.

Facing a disconnect between its growing operations and its market price, Sucro Limited is reviewing its strategy. What does this move reveal about the future of sugar?

GRAIL's revolutionary cancer test failed a key trial, wiping out billions and sparking a fraud lawsuit. A deep dive into the fallout for investors and science.

An investigation into nursing home giant Ensign reveals a troubling intersection of high finance, regulatory loopholes, and the vulnerable lives in its care.

Barry Diller wants to buy MGM Resorts, a company where he's a director. Now, a legal probe is asking if the deal serves all shareholders or just one.

A securities fraud lawsuit against Peabody Energy alleges a classic tale of corporate overpromise, exposing the risks of opaque disclosures in a volatile market.

Struggling apparel firm 707 Cayman Holdings appoints a Web3 pioneer to lead a pivot into AI and blockchain. Is it a visionary leap or a desperate gamble?